181 320
Table 1 – Patient characteristics
First author (year)
Origin
Duration of
patient
recruitment
Patients
(
n
)
Patients
with
PCa (
n
)
Age (yr)
PSA (ng/ml)
Gleason score No. of
previous
biopsies
PCa
diagnosis
before MRI
Country
Institution
Median Range Median Range Median Range
Auer (2016)
[16]Austria
Medical University of Innsbruck,
Medizinische Hochschule
Hannover
NR
50
NR
63
a
NR
7.3
a
NR
7 (3 + 4) 6–10
1
Yes (all)
Baldisserotto (2016)
[17]
Brazil
Pontifı´cia Universidade Cato´lica
do Rio Grande do Sul
2013.6–2015.6
54
33
65.9
a53–81
8.4
a
3–31
7 (3 + 4) 6–9
NR Yes (some)
De Visschere (2017)
[18]Belgium
Ghent University Hospital
2011.5–2014.12
245
144 66
44–85
9
1.4–935.5 7 (3 + 4)
6
0
No
El-Samei (2016)
[19]
Egypt
Al-Azher University, El-Minia
University
2014.5–2015.10
55
38
62
a
51–79
NR
NR
7
6–10
NR No
Feng (2016)
[20]China
Tongji Hospital
2013.6–2015.7
401
150
64.4
a34–88
10.7 0.2–1763 7 (4 + 3)
6– 8 NR NR
Kasel-Seibert (2016)
[21]
Germany
University Hospital Jena
2013.7–2015.3
82
31
65
48–81
13
1–111
7 (3 + 4) 6–9
1–5 No
Lin (2016)
[22]
Brazil, Taiwan Ribeira˜o Preto School of
Medicine, China Medical
University, Ribeira˜o Preto School
of Medicine
2011.5–2014.6
49
49
63
46–73
13.27 1.8–41.4
1
Yes (all)
Martorana (2016)
[23]
Italy
University of Modena and
Reggio Emilia, Perugia
University
2014.1–2016.2
157
79
65
47–79
b
10.7 1–75
6
6–8
1–3 No
Mertan (2016)
[24]
USA
National Cancer Institute
2015.3–2015.9
62
38
65.5 50.3–76.6 7.1
0.5–863 7 (3 + 4) 6–9
NR NR
Muller (2015)
[25]
USA,
the Netherlands
National Cancer Institute, AMC
University Hospital, Edward
He´bert School of Medicine
2011.12–2014.5
94
94
62
37–79
8.51 0.7–51.1 7 (3 + 4) 6–10
0
No
Park (2016)
[26]South Korea
Samsung Medical Center
2012.1–2014.12
456
456 65
46–81
3.97 3.8–4.2 NR
6
1
Yes (all)
Park (2016)
[27]South Korea
Yonsei University College of
Medicine
2012.1–2013.3
425
425 NR
NR
NR
1.4–156.9 5–6
5–10
1
Yes (all)
Polanec (2016)
[28]Vienna
Medical University of Vienna,
Confraternita¨t Vienna
2011.6–2015.9
65
NR
65.3
a62.3–87.4 10.8
a
4.2–74.5 7 (4 + 3) 6–9
0
No
Rastinehad (2015)
[29]USA
Icahn School of Medicine at
Mount Sinai, Fox Chase Cancer
Center, National Institutes of
Health, Hofstra North Shore LIJ
School of Medicine
2012.2–2014.11
312
202 65.1 60.3–70.3
b
7.3
5.0–11.4
b
NR
NR
NR No
Rosenkrantz (2016)
[30]USA
NYU Langone Medical Center
2013.9–2015.2
343
134 64
NR
5.8
NR
7 (3 + 4) 6–9
NR NR
Stanzione (2016)
[31]
Italy
University ‘‘Federico II’’,
Ospedale S. Maria delle Grazie
NR
82
34
65
a
43–84
8.8
a
NR
7 (3 + 4) 6–9
NR No
Tan (2016)
[32]
USA, Taiwan UCLA, Cathay General Hospital,
Hoag Hospital
2013.3–2016.12
106
63
66.5 43–79
7.9
5.6–10.6 7 (3 + 4) 6–10
0
Yes (some)
Tewes (2016)
[33]
Germany
Hannover Medical School,
Klinikumder Region Hannover
2012.12–2014.12
54
31
69.6
aNR
8.7
a
NR
6
6–9
0
No
Washino (2017)
[34]
Japan
Jichi Medical University Saitama
Medical Center
2010.6–2014.4
288
159 69
64–74
b
7.5
5.5–11
b
NR
NR
0
No
Woo (2016)
[35]
South Korea
Seoul National University
College of Medicine
2011.1–2013.12
105
105 69
49–79
8.22 0.9–44.2 7
6–7
1
Yes (all)
Zhao (2016)
[36]
China
Peking University First Hospital
2010.11–2013.12 372
185 68.5
aNR
15
a
NR
7
6–10
NR No
MRI = magnetic resonance imaging; NR = not reported; PCa = prostate cancer; PSA = prostate-specific antigen.
a
Mean.
b
Interquartile range.
E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 1 7 7 – 1 8 8
181